Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1
β Scribed by Thomas Pusl; Timo Vennegeerts; Ralf Wimmer; Gerald U. Denk; Ulrich Beuers; Christian Rust
- Book ID
- 116296192
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 138 KB
- Volume
- 367
- Category
- Article
- ISSN
- 0006-291X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ursodeoxycholic acid (UDCA) is used in the treatment of cholestatic liver diseases, but its mechanism of action is not yet well defined. The aim of this study was to explore the protective mechanisms of the taurine-conjugate of UDCA (tauroursodeoxycholic acid [TUDCA]) against glycochenodeoxycholic a
Tauroursodeoxycholic acid (TUDCA) is a cytoprotective bile acid frequently prescribed to patients with cholestatic diseases. Several mechanisms of action have been investigated, but the possibility that cyclic adenosine monophosphate responsive element binding protein (CREB), a transcription factor